Does acute and persistent metabolic dysregulation in COVID-19 point to novel biomarkers and future therapeutic strategies?
Year: 2021
Type: article
Abstract: Metabolomics changes in COVID-19 predict acute patient outcomes and suggest a role for a bioenergetic crisis. Thus, metabolomics changes in COVID-19 may serve as a biomarker and provide insight into pathogenic mechanisms and pharmacologic targets.https://bit.ly/2XkJeU8
Source: European Respiratory Journal
Institution: University of South Alabama
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Awards: G2169647586, Center for Clinical and Translational Science, mtDNA damage and DAMPs in multiple organ dysfunction syndrome, Metabolic Energy Crisis Signature Predicts Quality of Life in Survivors of Acute Respiratory Failure, G6508019130, DEEP SOUTH TRANSLATIONAL RESEARCH MENTORED CAREER DEVELOPMENT PROGRAM, MtDNA repair: An isolated pharmacologic target in acute lung injury
OpenAlex ID: W3205162192